Attenuated neutrophil axis in atopic dermatitis compared to psoriasis reflects TH17 pathway differences between these diseases

Nikhil Dhingra; Mayte Suárez-Fariñas; Judilyn Fuentes-Duculan; Julia K. Gittler; Avner Shemer; Assaf Raz; Vincent A. Fischetti; James G. Krueger; Emma Guttman-Yassky

doi:10.1016/j.jaci.2013.04.043

Attenuated neutrophil axis in atopic dermatitis compared to psoriasis reflects T_H17 pathway differences between these diseases

Nikhil Dhingra, Mayte Suárez-Fariñas, Judilyn Fuentes-Duculan, Julia K. Gittler, Avner Shemer, Assaf Raz, Vincent A. Fischetti, James G. Krueger, Emma Guttman-Yassky

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	498-501.e3
Journal	Journal of Allergy and Clinical Immunology
Volume	132
Issue number	2
DOIs	https://doi.org/10.1016/j.jaci.2013.04.043
State	Published - Aug 2013
Externally published	Yes

Access to Document

10.1016/j.jaci.2013.04.043

Cite this

Dhingra, N., Suárez-Fariñas, M., Fuentes-Duculan, J., Gittler, J. K., Shemer, A., Raz, A., Fischetti, V. A., Krueger, J. G., & Guttman-Yassky, E. (2013). Attenuated neutrophil axis in atopic dermatitis compared to psoriasis reflects T_H17 pathway differences between these diseases. Journal of Allergy and Clinical Immunology, 132(2), 498-501.e3. https://doi.org/10.1016/j.jaci.2013.04.043

@article{5279bb3f665d46ca8285e1781429007d,

title = "Attenuated neutrophil axis in atopic dermatitis compared to psoriasis reflects TH17 pathway differences between these diseases",

author = "Nikhil Dhingra and Mayte Su{\'a}rez-Fari{\~n}as and Judilyn Fuentes-Duculan and Gittler, {Julia K.} and Avner Shemer and Assaf Raz and Fischetti, {Vincent A.} and Krueger, {James G.} and Emma Guttman-Yassky",

note = "Funding Information: Disclosure of potential conflict of interest: E. Guttman-Yassky has consultant arrangements with LeoPharma, Stiefel, Bristol Meyers Squib, GlaxoSmithKlein, and Regeneron and has received payment for lectures, including service on speakers' bureaus, for Celgene and Merck . J. Krueger has received grants from The Rockefeller University ; has consultant arrangements and grants/grants pending with Centocor, Lilly, and Pfizer ; has consultant arrangements with Amgen; and has grants/grants pending with Merck . The rest of the authors declare that they have no relevant conflicts of interest. Funding Information: N.D., M.S.-F., and J.K. were supported by a grant (no. 5UL1RR024143-02 ) from the National Center for Research Resources (NCRR) , a component of the National Institutes of Health (NIH) , and the NIH Roadmap for Medical Research . E. G.-Y. was supported by the Dermatology Foundation Physician Scientist Career Development Award . ",

year = "2013",

month = aug,

doi = "10.1016/j.jaci.2013.04.043",

language = "אנגלית",

volume = "132",

pages = "498--501.e3",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Mosby Inc.",

number = "2",

}

Dhingra, N, Suárez-Fariñas, M, Fuentes-Duculan, J, Gittler, JK, Shemer, A, Raz, A, Fischetti, VA, Krueger, JG & Guttman-Yassky, E 2013, 'Attenuated neutrophil axis in atopic dermatitis compared to psoriasis reflects T_H17 pathway differences between these diseases', Journal of Allergy and Clinical Immunology, vol. 132, no. 2, pp. 498-501.e3. https://doi.org/10.1016/j.jaci.2013.04.043

TY - JOUR

T1 - Attenuated neutrophil axis in atopic dermatitis compared to psoriasis reflects TH17 pathway differences between these diseases

AU - Dhingra, Nikhil

AU - Suárez-Fariñas, Mayte

AU - Fuentes-Duculan, Judilyn

AU - Gittler, Julia K.

AU - Shemer, Avner

AU - Raz, Assaf

AU - Fischetti, Vincent A.

AU - Krueger, James G.

AU - Guttman-Yassky, Emma

N1 - Funding Information: Disclosure of potential conflict of interest: E. Guttman-Yassky has consultant arrangements with LeoPharma, Stiefel, Bristol Meyers Squib, GlaxoSmithKlein, and Regeneron and has received payment for lectures, including service on speakers' bureaus, for Celgene and Merck . J. Krueger has received grants from The Rockefeller University ; has consultant arrangements and grants/grants pending with Centocor, Lilly, and Pfizer ; has consultant arrangements with Amgen; and has grants/grants pending with Merck . The rest of the authors declare that they have no relevant conflicts of interest. Funding Information: N.D., M.S.-F., and J.K. were supported by a grant (no. 5UL1RR024143-02 ) from the National Center for Research Resources (NCRR) , a component of the National Institutes of Health (NIH) , and the NIH Roadmap for Medical Research . E. G.-Y. was supported by the Dermatology Foundation Physician Scientist Career Development Award .

PY - 2013/8

Y1 - 2013/8

UR - http://www.scopus.com/inward/record.url?scp=84881146016&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2013.04.043

DO - 10.1016/j.jaci.2013.04.043

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

AN - SCOPUS:84881146016

SN - 0091-6749

VL - 132

SP - 498-501.e3

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 2

ER -

Attenuated neutrophil axis in atopic dermatitis compared to psoriasis reflects TH17 pathway differences between these diseases

Access to Document

Other files and links

Cite this

Attenuated neutrophil axis in atopic dermatitis compared to psoriasis reflects T_H17 pathway differences between these diseases